Exiqon closes in on two new launches
![Foto: Exiqon](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article5905048.ece/ALTERNATES/schema-16_9/HR_CEO2.jpg)
Danish-based gene analysis company Exiqon looks set to cash in on a clinical collaboration with Professor Torben Ørntoft and his research team at the Institute for Molecular Medicine (MOMA) at Aarhus University Hospital.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Exiqon buys rights for prostate cancer biomarkers
For abonnenter
Exiqon’s US business has kicked into gear
For abonnenter
Exiqon CEO: We have created Amazon for life science
For abonnenter